Following the earnings announcement, WST stock plummeted 38% due to its disappointing guidance. Over a broader timeframe, its ...

West Pharmaceutical Services (WST) stock plummeted 38% on Thursday, making it the biggest decliner in the S&P 500. The sharp ...

West Pharmaceutical Services Inc.’s stock tumbled 33% Thursday, to lead S&P 500 decliners, after the manufacturer of ...

Shares of healthcare products company West Pharmaceutical Services (NYSE:WST) fell 34.9% in the afternoon session after the ...

West Pharmaceutical Services forecast full-year profit and revenue below Wall Street estimates on Thursday due to a strong ...

The S&P 500 advanced 1.0% on Thursday, Feb. 13, as an executive order deferred the possible implementation of reciprocal ...

Trade Desk sinks following a revenue miss, AppLovin surges after quarterly revenue soars 44%, and Intel extends the stock’s ...

Q4 2024 Earnings Call Transcript February 13, 2025 West Pharmaceutical Services, Inc. beats earnings expectations. Reported ...

We recently compiled a list of the Weak Earnings, Outlook Drag Shares of These 10 Firms on Thursday. In this article, we are ...

For 2025, West Pharmaceutical guided for sales between $2.88 billion and $2.91 billion as well as adjusted earnings per-share in the range of $6 and $6.20. Analysts polled by FactSet expected $3.04 ...

West Pharmaceutical reported Q4 earnings and revenue above expectations but issued a weak 2025 forecast. William Blair ...